This is the first study to present a comprehensive real‐world investigation into the prophylactic use of long‐acting granulocyte‐colony stimulating factor (G‐CSF) for managing chemotherapy‐induced neutropenia in patients with gastrointestinal cancer. The gene discussed is CSF3; the disease is neutropenia.